Rousseau, Julie <br/><br/>
Formulated siRNAs targeting Rankl prevent osteolysis and enhance chemotherapeutic response in osteosarcoma models.  [electronic resource] 

 -  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research  Oct 2011 
 - 2452-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-4681 
<br/><br/><label>Standard No.: </label>10.1002/jbmr.455  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--therapeutic use<br/>Base Sequence<br/>Blotting, Western<br/>Enzyme-Linked Immunosorbent Assay<br/>Flow Cytometry<br/>Immunohistochemistry<br/>Mice<br/>Mice, Nude<br/>Osteolysis--genetics<br/>Osteosarcoma--drug therapy<br/>RANK Ligand--genetics<br/>RNA, Small Interfering--genetics<br/>Rats